Valuation: Kenvue Inc.

Market Cap 33.04B 29.35B 27.4B 24.97B 47.1B 3,176B 47.53B 332B 128B 1,624B 124B 121B 5,211B P/E 2026 *
18.1x
P/E 2027 * 15.8x
Enterprise Value 40.14B 35.66B 33.28B 30.34B 57.22B 3,858B 57.75B 403B 156B 1,973B 151B 147B 6,330B EV / Sales 2026 *
2.57x
EV / Sales 2027 * 2.48x
Free-Float
98.88%
Yield 2026 *
4.91%
Yield 2027 * 5.01%
1 day-0.12%
1 week-3.37%
Current month-2.60%
1 month-10.09%
3 months-13.26%
6 months+0.35%
Current year-0.29%
1 week 17.16
Extreme 17.1614
18.08
1 month 17.16
Extreme 17.1614
18.98
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26
Starboard Value LP
OtherCompany 0 0% -
9/28/26 Free

Director

1,300 0.0001%
9/28/26 Free

Director

1,300 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-3.37%+9.35%-15.35% 33.04B
+0.67%-0.90%-4.70%-0.19% 337B
+0.27%-2.38%-0.39%-5.32% 223B
-0.23%-3.88%-9.09%-0.97% 128B
-0.32%-2.09%+7.60%+19.08% 67.17B
-0.16%-1.50%+16.42% - 45.15B
-2.29%-5.50%-27.61%-25.54% 44.87B
+1.97%-2.65%+3.60%-35.86% 33.27B
+0.02%-4.13%-23.05%-20.71% 31.38B
-1.23%-2.11%+8.49%+24.40% 19.73B
Average -0.22%-2.69%-1.94%-6.72% 96.23B
Weighted average by Cap. -0.09%-2.18%-3.06%-3.39%

Financials

2026 *2027 *
Net sales 15.6B 13.86B 12.93B 11.79B 22.23B 1,499B 22.44B 157B 60.65B 766B 58.55B 57.28B 2,460B 15.97B 14.19B 13.24B 12.07B 22.76B 1,535B 22.97B 160B 62.09B 785B 59.95B 58.65B 2,518B
Net income 1.83B 1.62B 1.52B 1.38B 2.6B 176B 2.63B 18.34B 7.11B 89.79B 6.86B 6.71B 288B 2.1B 1.87B 1.74B 1.59B 3B 202B 3.02B 21.09B 8.17B 103B 7.89B 7.72B 332B
Net Debt 7.1B 6.31B 5.89B 5.37B 10.12B 683B 10.21B 71.25B 27.61B 349B 26.66B 26.08B 1,120B 6.53B 5.8B 5.42B 4.94B 9.31B 628B 9.4B 65.56B 25.4B 321B 24.53B 23.99B 1,030B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-10-02 US$17.20 -0.12% 13,996,786
26-10-01 US$17.22 -2.49% 22,209,306
26-09-30 US$17.66 -1.40% 25,407,189
26-09-29 US$17.91 +0.17% 19,194,868
26-09-28 US$17.88 +0.45% 16,029,406
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.20USD
Average target price
19.50USD
Spread / Average Target
+13.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock